To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.

Summary

This bill allows certain small businesses a new tax credit for 10% of their qualified drug threat mitigation research expenses. Such expenses include research into mitigating or treating the effects of specified drugs, including any emerging drugs, fentanyl, a fentanyl-related substance, or methamphetamine.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 11 January 2024

   Introduced

   Referred to the House Committee on Ways and Means.

   Source: IntroReferral

2. 11 January 2024

   Introduced

   Introduced in House

   Source: IntroReferral

3. 11 January 2024

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 11 January 2024 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 11 January 2024

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 11 January 2024

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 11 January 2024

  Open at official source

Sponsors

• Rep. Neguse, Joe [D-CO-2] · D · Sponsor
• Rep. Dean, Madeleine [D-PA-4] · D · Sponsor
• Rep. Bacon, Don [R-NE-2] · R · Sponsor
• David Trone · D · Sponsor
• Rep. Lawler, Michael [R-NY-17] · R · Sponsor
• Rep. Ciscomani, Juan [R-AZ-6] · R · Sponsor
• Marcus Molinaro · R · Cosponsor
• · hswm00 · Standing

Related records

No cross-record relationships stored yet.